In samples collected from patients suffering hepatic carcinoma, HIF-3α was shown to be upregulated in 46% of the samples; nonetheless, it was also observed to be downregulated in another 42% of cases [66]. This evidence concerns the gene HIF3A and hepatocellular carcinoma.